Commission Implementing Regulation (EU) 2021/51 of 22 January 2021 authorising a change of the conditions of use of the novel food ‘trans-resveratrol’ under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

• CELEX: Implementing Regulation (EU) 2021/51
• Articles: 3

Article 1

1.   The entry in the Union list of authorised novel foods as provided for in Article 6 of Regulation (EU) 2015/2283 and included in Implementing Regulation (EU) 2017/2470, referring to the ‘ trans -resveratrol’, shall be amended as specified in the Annex to this Regulation.

2.   The entry in the Union list referred to in paragraph 1 shall include the conditions of use and labelling requirements laid down in the Annex.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

In the Annex to Implementing Regulation (EU) 2017/2470, the entry for ‘Trans-resveratrol’ in Table 1 (Authorised novel foods) is replaced by the following:

Authorised novel food

Conditions under which the novel food may be used

Additional specific labelling requirements

Other requirements

Data protection

‘ Trans -resveratrol

Specified food category

Maximum levels

1.

The designation of the novel food on the labelling of the food supplements containing it shall be “ Trans -resveratrol”.

2.

The labelling of food supplements containing trans -resveratrol shall bear a statement that people using medicines should only consume the product under medical supervision.’

Food supplements as defined in Directive 2002/46/EC for the adult population

150 mg/day